<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1020-3397</journal-id>
<journal-title><![CDATA[Eastern Mediterranean Health Journal]]></journal-title>
<abbrev-journal-title><![CDATA[East. Mediterr. health j.]]></abbrev-journal-title>
<issn>1020-3397</issn>
<publisher>
<publisher-name><![CDATA[Alexandria: WHO, Regional Office for the Eastern Mediterranean]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1020-33972007000500003</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Asthma and other allergic diseases in 13-14-year-old schoolchildren in Urmia: an ISAAC study]]></article-title>
<article-title xml:lang="fr"><![CDATA[Étude ISAAC : asthme et allergies chez des écoliers de 13-14 ans résidant à Urmia]]></article-title>
<article-title xml:lang="ar"><![CDATA[&#1575;&#1604;&#1585;&#1576;&#1608; &#1608;&#1587;&#1575;&#1574;&#1585; &#1575;&#1604;&#1571;&#1605;&#1585;&#1575;&#1590; &#1575;&#1604;&#1571;&#1585;&#1614;&#1580;&#1610;&#1617;&#1614;&#1577; &#1604;&#1583;&#1609; &#1575;&#1604;&#1578;&#1604;&#1575;&#1605;&#1610;&#1584; &#1601;&#1610; &#1593;&#1605;&#1585; 13 - 14 &#1593;&#1575;&#1605;&#1575;&#1611; &#1601;&#1610; &#1605;&#1583;&#1610;&#1606;&#1577; &#1571;&#1608;&#1585;&#1605;&#1610;&#1577;]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rahimi Rad]]></surname>
<given-names><![CDATA[M.H.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hejazi]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Behrouzian]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Urmia University of Medical Sciences Department of Internal Medicine ]]></institution>
<addr-line><![CDATA[Urmia West Azerbaijan]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Tabriz University of Medical Sciences Department of Internal Medicine ]]></institution>
<addr-line><![CDATA[Tabriz East Azerbaijan]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<volume>13</volume>
<numero>5</numero>
<fpage>1005</fpage>
<lpage>1016</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_arttext&amp;pid=S1020-33972007000500003&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_abstract&amp;pid=S1020-33972007000500003&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_pdf&amp;pid=S1020-33972007000500003&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[We determined the prevalence and risk factors of asthma, allergic rhinitis and atopic eczema in 3000 13-14-year-old schoolchildren in Urmia, Islamic Republic of Iran. We used the International Study of Asthma and Allergies in Childhood (ISAAC) written and video questionnaires. With the written questionnaire, the prevalence of current symptoms (within the past 12 months) was: wheeze 14.5%, allergic rhinitis 23.6% and eczema 10.1%. Self-reported asthma ever was only 2.1%. With the video questionnaire, the prevalence of wheeze was lower; 7.4% for wheeze at rest ever and 4.6% during the past 12 months. Boys had a significantly higher prevalence for most items examined except for eczema.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Nous avons déterminé la prévalence et les facteurs de risque de l’asthme, de la rhinite allergique et de l’eczéma atopique ( ou constitutionnel) chez un échantillon de 3000 écoliers âgés de 13 à 14 ans résidant à Urmia (République islamique d’Iran). Pour ce faire, nous avons eu recours aux questionnaires écrits et vidéo de l’étude ISAAC (pour International Study of Asthma and Allergies in Childhood, Étude internationale de l’asthme et des allergies chez l’enfant). Le questionnaire écrit a fait apparaître la prévalence suivante des symptômes actifs (c.-à.-d. s’étant manifestés au cours des 12 derniers mois) : respiration sifflante : 14,5 %, rhinite allergique : 23,6 % et eczéma 10,1 %. Les cas d’asthme autorapportés ne dépassaient pas 2,1 %. Le questionnaire vidéo a permis d’établir une prévalence inférieure pour la respiration sifflante, à savoir un maximum de 7,4 % au repos et 4,6 % au cours des 12 derniers mois. Pour la plupart des items, exception faite de l’eczéma, la prévalence s’est avérée significativement supérieure chez les individus de sexe masculin.]]></p></abstract>
<abstract abstract-type="short" xml:lang="ar"><p><![CDATA[&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577; &#1602;&#1575;&#1605; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1576;&#1578;&#1581;&#1583;&#1610;&#1583; &#1605;&#1593;&#1583;&#1617;&#1614;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1585;&#1576;&#1608;&#1548; &#1608;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1571;&#1606;&#1601;&#1548; &#1608;&#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577; &#1575;&#1604;&#1578;&#1571;&#1578;&#1600;&#1617;&#1615;&#1576;&#1610;&#1577;&#1548; &#1608;&#1593;&#1608;&#1575;&#1605;&#1604; &#1575;&#1582;&#1578;&#1591;&#1575;&#1585;&#1607;&#1575;&#1548; &#1604;&#1583;&#1609; 3000 &#1578;&#1604;&#1605;&#1610;&#1584;&#1548; &#1571;&#1593;&#1605;&#1575;&#1585;&#1607;&#1605; 13 - 14 &#1593;&#1575;&#1605;&#1575;&#1611; &#1601;&#1610; &#1605;&#1583;&#1610;&#1606;&#1577; &#1571;&#1608;&#1585;&#1605;&#1610;&#1577; &#1575;&#1604;&#1573;&#1610;&#1585;&#1575;&#1606;&#1610;&#1577;&#1548; &#1605;&#1615;&#1587;&#1618;&#1578;&#1614;&#1582;&#1618;&#1583;&#1616;&#1605;&#1610;&#1606;&#1614; &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1575;&#1604;&#1603;&#1578;&#1575;&#1576;&#1610; &#1608;&#1575;&#1604;&#1601;&#1610;&#1583;&#1610;&#1608;&#1610; &#1575;&#1604;&#1582;&#1575;&#1589; &#1576;&#1575;&#1604;&#1583;&#1585;&#1575;&#1587;&#1577; &#1575;&#1604;&#1583;&#1608;&#1604;&#1610;&#1577; &#1604;&#1604;&#1585;&#1576;&#1608; &#1608;&#1575;&#1604;&#1571;&#1585;&#1614;&#1580;&#1610;&#1617;&#1575;&#1578; &#1601;&#1610; &#1605;&#1585;&#1581;&#1604;&#1577; &#1575;&#1604;&#1591;&#1601;&#1608;&#1604;&#1577; (ISAAC). &#1608;&#1602;&#1583; &#1583;&#1604;&#1617;&#1614; &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1575;&#1604;&#1603;&#1578;&#1575;&#1576;&#1610; &#1593;&#1604;&#1609; &#1571;&#1606; &#1605;&#1593;&#1583;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1571;&#1593;&#1585;&#1575;&#1590; &#1575;&#1604;&#1581;&#1575;&#1604;&#1610;&#1577; (&#1582;&#1604;&#1575;&#1604; &#1575;&#1604;&#1573;&#1579;&#1606;&#1610; &#1593;&#1588;&#1585; &#1588;&#1607;&#1585;&#1575;&#1611; &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;) &#1603;&#1575;&#1606; &#1593;&#1604;&#1609; &#1575;&#1604;&#1606;&#1581;&#1608; &#1575;&#1604;&#1578;&#1575;&#1604;&#1610;: &#1575;&#1604;&#1571;&#1586;&#1610;&#1586; &#1576;&#1606;&#1587;&#1576;&#1577; 14.5%&#1548; &#1608;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1571;&#1606;&#1601; &#1576;&#1606;&#1587;&#1576;&#1577; 23.6%&#1548; &#1608;&#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577; &#1576;&#1606;&#1587;&#1576;&#1577; 10.1%. &#1608;&#1604;&#1605; &#1578;&#1586;&#1583; &#1606;&#1587;&#1576;&#1577; &#1575;&#1604;&#1585;&#1576;&#1608; &#1575;&#1604;&#1605;&#1576;&#1604;&#1594; &#1584;&#1575;&#1578;&#1610;&#1575;&#1611; &#1593;&#1604;&#1609; 2.1%. &#1571;&#1605;&#1575; &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1575;&#1604;&#1601;&#1610;&#1583;&#1610;&#1608;&#1610; &#1601;&#1602;&#1583; &#1576;&#1610;&#1617;&#1614;&#1606; &#1571;&#1606; &#1605;&#1593;&#1583;&#1617;&#1614;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1571;&#1586;&#1610;&#1586; &#1603;&#1575;&#1606; &#1571;&#1582;&#1618;&#1601;&#1614;&#1590;&#1563; &#1601;&#1602;&#1583; &#1576;&#1604;&#1594;&#1578; &#1606;&#1587;&#1576;&#1578;&#1607; &#1601;&#1610; &#1581;&#1575;&#1604;&#1577; &#1575;&#1604;&#1585;&#1575;&#1581;&#1577; 7.4%&#1548; &#1608;4.6% &#1582;&#1604;&#1575;&#1604; &#1575;&#1604;&#1575;&#1579;&#1606;&#1610; &#1593;&#1588;&#1585; &#1588;&#1607;&#1585;&#1575;&#1611; &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;. &#1608;&#1603;&#1575;&#1606; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1580;&#1605;&#1610;&#1593; &#1575;&#1604;&#1576;&#1606;&#1608;&#1583; &#1575;&#1604;&#1605;&#1601;&#1581;&#1608;&#1589;&#1577; &#1571;&#1593;&#1604;&#1609; &#1576;&#1583;&#1585;&#1580;&#1577; &#1610;&#1615;&#1593;&#1618;&#1578;&#1614;&#1583;&#1617;&#1615; &#1576;&#1607;&#1575; &#1573;&#1581;&#1589;&#1575;&#1574;&#1610;&#1575;&#1611; &#1604;&#1583;&#1609; &#1575;&#1604;&#1584;&#1603;&#1608;&#1585;&#1548; &#1576;&#1575;&#1587;&#1578;&#1579;&#1606;&#1575;&#1569; &#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577;.]]></p></abstract>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="verdana" size="2"><b>RESEARCH ARTICLES</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Asthma and other    allergic diseases in 13-14-year-old schoolchildren in Urmia: an ISAAC study    </b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Étude ISAAC    : asthme et allergies chez des écoliers de 13-14 ans résidant à Urmia </b></font></p>     <p>&nbsp;</p>     <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>&#1575;&#1604;&#1585;&#1576;&#1608;    &#1608;&#1587;&#1575;&#1574;&#1585; &#1575;&#1604;&#1571;&#1605;&#1585;&#1575;&#1590;    &#1575;&#1604;&#1571;&#1585;&#1614;&#1580;&#1610;&#1617;&#1614;&#1577; &#1604;&#1583;&#1609;    &#1575;&#1604;&#1578;&#1604;&#1575;&#1605;&#1610;&#1584; &#1601;&#1610; &#1593;&#1605;&#1585;    13 - 14 &#1593;&#1575;&#1605;&#1575;&#1611; &#1601;&#1610; &#1605;&#1583;&#1610;&#1606;&#1577;    &#1571;&#1608;&#1585;&#1605;&#1610;&#1577;</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>M.H. Rahimi    Rad<sup>I</sup>; M.E. Hejazi<sup>II</sup>; R. Behrouzian<sup>I</sup> </b></font></p>     ]]></body>
<body><![CDATA[<p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&#1605;&#1581;&#1605;&#1583;    &#1581;&#1587;&#1610;&#1606; &#1585;&#1581;&#1610;&#1605;&#1610; &#1585;&#1575;&#1583;&#1548;    &#1605;&#1581;&#1605;&#1583; &#1573;&#1587;&#1605;&#1575;&#1593;&#1610;&#1604;    &#1581;&#1580;&#1575;&#1586;&#1610;&#1548; &#1585;&#1575;&#1605;&#1610;&#1606;    &#1576;&#1607;&#1585;&#1608;&#1586;&#1610;&#1575;&#1606;</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Department    of Internal Medicine, Urmia University of Medical Sciences, Urmia, West Azerbaijan,    Islamic Republic of Iran (Correspondence to M.H. Rahimi Rad: <a href="mailto:rahimirad@umsu.ac.ir">rahimirad@umsu.ac.ir</a>)    <br>   <sup>II</sup>Department of Internal Medicine, Tabriz University of Medical Sciences,    Tabriz, East Azerbaijan, Islamic Republic of Iran </font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <HR size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> We determined    the prevalence and risk factors of asthma, allergic rhinitis and atopic eczema    in 3000 13-14-year-old schoolchildren in Urmia, Islamic Republic of Iran. We    used the International Study of Asthma and Allergies in Childhood (ISAAC) written    and video questionnaires. With the written questionnaire, the prevalence of    current symptoms (within the past 12 months) was: wheeze 14.5%, allergic rhinitis    23.6% and eczema 10.1%. Self-reported asthma ever was only 2.1%. With the video    questionnaire, the prevalence of wheeze was lower; 7.4% for wheeze at rest ever    and 4.6% during the past 12 months. Boys had a significantly higher prevalence    for most items examined except for eczema. </font></p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RÉSUMÉ</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> Nous avons déterminé    la prévalence et les facteurs de risque de l’asthme, de la rhinite allergique    et de l’eczéma atopique ( ou constitutionnel) chez un échantillon de 3000 écoliers    âgés de 13 à 14 ans résidant à Urmia (République islamique d’Iran). Pour ce    faire, nous avons eu recours aux questionnaires écrits et vidéo de l’étude ISAAC    (pour International Study of Asthma and Allergies in Childhood, Étude internationale    de l’asthme et des allergies chez l’enfant). Le questionnaire écrit a fait apparaître    la prévalence suivante des symptômes actifs (c.-à.-d. s’étant manifestés au    cours des 12 derniers mois) : respiration sifflante : 14,5 %, rhinite allergique    : 23,6 % et eczéma 10,1 %. Les cas d’asthme autorapportés ne dépassaient pas    2,1 %. Le questionnaire vidéo a permis d’établir une prévalence inférieure pour    la respiration sifflante, à savoir un maximum de 7,4 % au repos et 4,6 % au    cours des 12 derniers mois. Pour la plupart des items, exception faite de l’eczéma,    la prévalence s’est avérée significativement supérieure chez les individus de    sexe masculin.</font></p> <hr size="1" noshade>     <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577;</b></font></p>     ]]></body>
<body><![CDATA[<p align="right"> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1602;&#1575;&#1605;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1576;&#1578;&#1581;&#1583;&#1610;&#1583;    &#1605;&#1593;&#1583;&#1617;&#1614;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585;    &#1575;&#1604;&#1585;&#1576;&#1608;&#1548; &#1608;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576;    &#1575;&#1604;&#1571;&#1606;&#1601;&#1548; &#1608;&#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577;    &#1575;&#1604;&#1578;&#1571;&#1578;&#1600;&#1617;&#1615;&#1576;&#1610;&#1577;&#1548;    &#1608;&#1593;&#1608;&#1575;&#1605;&#1604; &#1575;&#1582;&#1578;&#1591;&#1575;&#1585;&#1607;&#1575;&#1548;    &#1604;&#1583;&#1609; 3000 &#1578;&#1604;&#1605;&#1610;&#1584;&#1548; &#1571;&#1593;&#1605;&#1575;&#1585;&#1607;&#1605;    13 - 14 &#1593;&#1575;&#1605;&#1575;&#1611; &#1601;&#1610; &#1605;&#1583;&#1610;&#1606;&#1577;    &#1571;&#1608;&#1585;&#1605;&#1610;&#1577; &#1575;&#1604;&#1573;&#1610;&#1585;&#1575;&#1606;&#1610;&#1577;&#1548;    &#1605;&#1615;&#1587;&#1618;&#1578;&#1614;&#1582;&#1618;&#1583;&#1616;&#1605;&#1610;&#1606;&#1614;    &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1575;&#1604;&#1603;&#1578;&#1575;&#1576;&#1610;    &#1608;&#1575;&#1604;&#1601;&#1610;&#1583;&#1610;&#1608;&#1610; &#1575;&#1604;&#1582;&#1575;&#1589;    &#1576;&#1575;&#1604;&#1583;&#1585;&#1575;&#1587;&#1577; &#1575;&#1604;&#1583;&#1608;&#1604;&#1610;&#1577;    &#1604;&#1604;&#1585;&#1576;&#1608; &#1608;&#1575;&#1604;&#1571;&#1585;&#1614;&#1580;&#1610;&#1617;&#1575;&#1578;    &#1601;&#1610; &#1605;&#1585;&#1581;&#1604;&#1577; &#1575;&#1604;&#1591;&#1601;&#1608;&#1604;&#1577;    (ISAAC). &#1608;&#1602;&#1583; &#1583;&#1604;&#1617;&#1614; &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606;    &#1575;&#1604;&#1603;&#1578;&#1575;&#1576;&#1610; &#1593;&#1604;&#1609; &#1571;&#1606;    &#1605;&#1593;&#1583;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1571;&#1593;&#1585;&#1575;&#1590;    &#1575;&#1604;&#1581;&#1575;&#1604;&#1610;&#1577; (&#1582;&#1604;&#1575;&#1604;    &#1575;&#1604;&#1573;&#1579;&#1606;&#1610; &#1593;&#1588;&#1585; &#1588;&#1607;&#1585;&#1575;&#1611;    &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;) &#1603;&#1575;&#1606; &#1593;&#1604;&#1609;    &#1575;&#1604;&#1606;&#1581;&#1608; &#1575;&#1604;&#1578;&#1575;&#1604;&#1610;:    &#1575;&#1604;&#1571;&#1586;&#1610;&#1586; &#1576;&#1606;&#1587;&#1576;&#1577;    14.5%&#1548; &#1608;&#1575;&#1604;&#1578;&#1607;&#1575;&#1576; &#1575;&#1604;&#1571;&#1606;&#1601;    &#1576;&#1606;&#1587;&#1576;&#1577; 23.6%&#1548; &#1608;&#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577;    &#1576;&#1606;&#1587;&#1576;&#1577; 10.1%. &#1608;&#1604;&#1605; &#1578;&#1586;&#1583;    &#1606;&#1587;&#1576;&#1577; &#1575;&#1604;&#1585;&#1576;&#1608; &#1575;&#1604;&#1605;&#1576;&#1604;&#1594;    &#1584;&#1575;&#1578;&#1610;&#1575;&#1611; &#1593;&#1604;&#1609; 2.1%. &#1571;&#1605;&#1575;    &#1575;&#1604;&#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1575;&#1604;&#1601;&#1610;&#1583;&#1610;&#1608;&#1610;    &#1601;&#1602;&#1583; &#1576;&#1610;&#1617;&#1614;&#1606; &#1571;&#1606; &#1605;&#1593;&#1583;&#1617;&#1614;&#1604;    &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1571;&#1586;&#1610;&#1586;    &#1603;&#1575;&#1606; &#1571;&#1582;&#1618;&#1601;&#1614;&#1590;&#1563; &#1601;&#1602;&#1583;    &#1576;&#1604;&#1594;&#1578; &#1606;&#1587;&#1576;&#1578;&#1607; &#1601;&#1610;    &#1581;&#1575;&#1604;&#1577; &#1575;&#1604;&#1585;&#1575;&#1581;&#1577; 7.4%&#1548;    &#1608;4.6% &#1582;&#1604;&#1575;&#1604; &#1575;&#1604;&#1575;&#1579;&#1606;&#1610;    &#1593;&#1588;&#1585; &#1588;&#1607;&#1585;&#1575;&#1611; &#1575;&#1604;&#1587;&#1575;&#1576;&#1602;&#1577;.    &#1608;&#1603;&#1575;&#1606; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1580;&#1605;&#1610;&#1593;    &#1575;&#1604;&#1576;&#1606;&#1608;&#1583; &#1575;&#1604;&#1605;&#1601;&#1581;&#1608;&#1589;&#1577;    &#1571;&#1593;&#1604;&#1609; &#1576;&#1583;&#1585;&#1580;&#1577; &#1610;&#1615;&#1593;&#1618;&#1578;&#1614;&#1583;&#1617;&#1615;    &#1576;&#1607;&#1575; &#1573;&#1581;&#1589;&#1575;&#1574;&#1610;&#1575;&#1611;    &#1604;&#1583;&#1609; &#1575;&#1604;&#1584;&#1603;&#1608;&#1585;&#1548; &#1576;&#1575;&#1587;&#1578;&#1579;&#1606;&#1575;&#1569;    &#1575;&#1604;&#1573;&#1603;&#1586;&#1610;&#1605;&#1577;. </font></p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Introduction</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">About 300 million    people around the globe suffer from asthma, and 255 000 people died of asthma    in 2005 &#91;<i>1</i>&#93;. The surveillance of asthma as part of a global World Health    Organization (WHO) programme is essential &#91;<i>2</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The prevalence    of asthma and other allergic diseases varies among nations and countries. This    is partly due to a true differences in the prevalence of the disease and partly    due to differences in definition or the study methodology. The etiology of asthma    and allergic diseases remains poorly understood, despite considerable research.    The International Study of Asthma and Allergies in Childhood (ISAAC) was founded    to maximize the value of epidemiological research into asthma and allergic disease    by establishing a standardized methodology and facilitating international collaboration.    The ISAAC project has 3 phases. Phase I uses core questionnaires to evaluate    the prevalence and severity of asthma and allergic disease in different populations.    Phase II investigates possible etiological factors. Phase III investigates whether    asthma prevalence is increasing &#91;<i>3</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">WHO collaborates    in ISAAC and, more particularly, in the implementation of the study in developing    countries with areas of severe air pollution. A preliminary objective is to    obtain information on the association between childhood asthma and air pollution.    The first results of ISAAC have shown the prevalence of asthma symptoms varies    from 1.6% to 36.8% &#91;<i>1,3</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The aim of our    study was to investigate the prevalence, severity and related factors of asthma,    rhinitis and atopic eczema in 13-14-year-old schoolchildren in Urmia the capital    of western Azerbaijan, Islamic Republic of Iran using the ISAAC protocol, and    to compare our results with other studies using the same protocol.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Methods</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Study population</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The population    of interest in ISAAC is 2 age groups of schoolchildren: 13-14 years and 6-7    years. The older age group has been chosen to reflect the period when mortality    from asthma is commoner, and to enable the use of both a self-completed questionnaire    and a video questionnaire &#91;<i>3</i>&#93;. In this cross-sectional study we decided    to focus on 13-14-year-old schoolchildren. They were selected from 25 schools    among 81 secondary schools by random cluster sampling. In line with the ISAAC    committee recommendations, we aimed to recruit 3000 schoolchildren. With a sample    size of 3000, the power to detect a statistically significant difference in    the 1-year prevalence of wheezing and severe asthma between 2 centres would    be 99% and 90% respectively, at the 1% level of significance &#91;<i>3</i>&#93;. </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The study was approved    by the Research Committee of Urmia University of Medical Sciences. Letters with    explanation of the purpose of the study were sent to the parents the of study    group.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Students completed    the questionnaires during class hours under the supervision of their teachers    and members of Urmia University of Medical Sciences Students’ Research Committee.    No students declined to participate. Children who were selected but were absent    on the school visiting day completed the questionnaire on another day.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Questionnaires</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We used the translated    Persian versions of the ISAAC questionnaires. They had already been translated    according to ISAAC recommendations and used in the Iranian branch of the ISAAC    study in Tehran and Rasht and published by ISAAC Steering Committee report &#91;<i>4,5</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Both the written    questionnaire and the international version (AVQ3.0) of the ISAAC video questionnaire    on asthma symptoms were used. Epidemiological studies rely largely on reported    symptoms such as dyspnoea, wheezing, chest tightness, and cough. Although symptoms    are sensitive for the presence of asthma, they are relatively nonspecific. Furthermore,    they may be influenced by perception, recollection, culture, and the interviewer.    To counter the problem, ISAAC uses both written and video questionnaires to    determine the prevalence and severity of asthma symptoms. Showing, rather than    describing, symptoms and signs of asthma may provide more accurate recognition    of asthma without the potential biases of written questionnaires</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The ISAAC written    questionnaire includes questions on past and current wheezing episodes, wheezing    frequency, sleep disturbance, speech limitation during attacks, exercise-induced    wheezing and persistent cough unrelated to respiratory infections. Other questions    are concerned with the presence and severity of rhinitis and atopic eczema.    The video questionnaire explores asthma symptoms and severity.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Definitions    of terms</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The terms used    throughout the paper are shown below and relate to an affirmative response to    the questions indicated.</font></p>     ]]></body>
<body><![CDATA[<blockquote>        <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">        Wheeze ever: Have you ever had wheezing or whistling in the chest at any time      in the past?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">        Current wheezing: In the past 12 months, have you had wheezing or whistling      in the chest?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Severe wheeze in the past year: In the past 12 months, has wheezing ever been      severe enough to limit your speech to only 1 or 2 words at a time between      breaths?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Asthma ever: Have you ever had asthma?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Exercise-induced wheeze in the past year: In the past 12 months, has your      chest sounded wheezy during or after exercise?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Nocturnal cough in the past year: In the past 12 months, have you had a dry      cough at night, apart from a cough associated with a cold or a chest infection?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Allergic rhinitis ever: Have you ever had a problem with sneezing, or a runny,      or a blocked nose when you did not have a cold or the flu?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Current allergic rhinitis: In the past 12 months, have you had a problem with      sneezing, or a runny, or a blocked nose when you did not have a cold or the      flu?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Current rhinoconjunctivitis: In the past 12 months, has this nose problem      been accompanied by itchy/watery eyes?</font></p>       ]]></body>
<body><![CDATA[<p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Hay fever ever: Have you ever had hay fever?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Itchy rash ever: Have you ever had an itchy rash which came and went for at      least 6 months?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Current itchy rash: Have you had this itchy rash at any time in the past 12      months?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Itchy flexural rash in the last year: Has this itchy rash at any time affected      any of the following places: the folds of the elbows, behind the knees, in      front of the ankles, under the buttocks, or around the neck, ears or eyes?</font></p>       <p><font face="Symbol" size="2">·</font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">           Eczema ever (skin allergy ever): Have you ever had eczema (skin allergy)?</font></p> </blockquote>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Statistical    analysis</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The data were entered    into the computer according to ISAAC Committee instructions. The data were analysed    using <i>SPSS</i>, version 11. We calculated the prevalence for each of the    symptoms. We made a comparison between males and females using the chi-squared    test and <i>P</i>-value &lt; 0.05 was considered significant. We also assessed    the correlation between current wheezing and wheezing ever and some associated    factors.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Results</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In all, 3053 students    were given the questionnaires, 53 of which were unfilled or too incomplete;    thus the results of 3000 (1500 boys and 1500 girls) questionnaires were analysed.    Missing data for key questions, e.g. presence of symptoms ever of any of the    conditions ranged from 0.1% to 0.3%. As recommended by the ISAAC Committee these    missing data were included in denominators when calculating prevalence.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Written questionnaire</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#tab1">Table    1</a> shows the prevalence ever and currently of asthma, rhinitis and atopic    eczema overall and by sex in our sample. In general, more children had respiratory    and allergic rhinitis symptoms than had medically diagnosed illness. Rhinitis    ever (31.6%) was the most commonly reported symptom. Apart from eczema ever,    boys were significantly more likely than girls to report all the other conditions    included in the questionnaire. There were no significant sex differences for    eczema or chronic rash.</font></p>     <p><a name="tab1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a02tab01.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#fig1">Figure    1</a> shows the overlap of asthma, eczema and allergic rhinitis. While 19.5%    of the 13-14-year-olds reported having at least 1 of these conditions in the    past 12 months, only 3.5% reported having all 3.</font></p>     <p><a name="fig1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a02fig01.gif"></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Video questionnaire</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The responses to    the video questionnaire are shown in <a href="#tab2">Table 2</a>. Similar to    the written questionnaire, boys had a significantly higher prevalence for most    items, particularly exercise-induced wheeze. There were no significant differences    between the sexes with regard to wheeze at rest ever, nocturnal wheeze in the    past year, nocturnal wheeze <u>&gt;</u> 1 times per month, and nocturnal cough    <u>&gt;</u> 1 times per month.</font></p>     <p><a name="tab2"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a02tab02.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#tab3">Table    3</a> shows the association between various risk factors and wheezing ever and    current wheezing. There were significant associations between current wheeze    and male sex, rhinitis ever, eczema ever, acetaminophen at least once a month,    cat in the home and living on a busy road. As regards wheezing ever, there were    significant associations with male sex, rhinitis ever, eczema ever, acetaminophen    at least once a month, cat in the home, paternal smoking, maternal education    of high school or university level, and living on a busy road.</font></p>     <p><a name="tab3"></a></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&nbsp;</font></p>     ]]></body>
<body><![CDATA[<p align="center"><img src="/img/revistas/emhj/v13n5/a01tab03.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The use of the    standard ISAAC protocol permits comparison of our results in Urmia with other    cities and countries.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The summary results    of phase I of the ISAAC survey in 56 countries has been published &#91;<i>4,5</i>&#93;.    There were between 20-fold and 60-fold differences among countries in the prevalence    of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema with between    4-fold and 12-fold variations between the 10th and 90th percentile for the different    disorders. The self-reported 12-month prevalence of wheezing in children aged    13-14 years ranged from 2.1% in Indonesia to 32.2% in the United Kingdom (UK).    The prevalence was highest (&gt; 20%) in English-speaking countries (UK, New    Zealand, Australia and North America and some Latin American countries (Peru    and Costa Rica). Taken together, the data suggest that there are more cases    of asthma in more affluent countries &#91;<i>4,5</i>&#93;. In the ISAAC study, the Islamic    Republic of Iran (Rasht and Tehran) was ranked 28th for a 12-month prevalence    of wheezing (12.4% Tehran, 9.7% Rasht) &#91;<i>4,5</i>&#93;. In our study, the prevalence    of current wheeze among 13-14-year-old children was 14.5% which is lower than    the UK (32.2%), New Zealand (30.2%) and Australia (29.4%) but higher than China    (4.2%), Greece (3.7%) and Indonesia (2.1%) &#91;<i>5</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In a study using    ISAAC protocol in Diyarbakir in Turkey, a city near Urmia, the prevalence rates    of wheezing, rhinitis and chronic rash in the previous 12 months were 14.7%,    39.9% and 11.8% respectively. Our findings for these conditions were 14.5%,    31.6% and 10.1% respectively &#91;<i>6</i>&#93;. In Urmia, like Diyarbakir, rhinitis    was commoner than wheezing and rash but our prevalence was slightly lower than    Diyarbakir. For wheezing our results are similar to Diyarbakir and Kuwait (16.1%)    &#91;<i>7</i>&#93;. In another neighbouring country, Iraq, wheezing in the past 12 months    was reported by 15.7% of the 12-13-year-olds &#91;<i>8</i> &#93;</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There are few reports    regarding asthma status in Iranian children. In studies carried out as part    of the ISAAC protocol in Tehran in 1994 and 2002, the prevalences of current    wheezing were reported as 12.4% &#91;5&#93; and 10.6%  &#91;<i>9</i>&#93; respectively. We found    a slightly higher rate among schoolchildren in Urmia. In Isfahan the prevalence    of wheezing and dyspnoea among primary-school children was 3.9% &#91;<i>10</i>&#93;,    which is lower than our finding. The difference is most likely related to study    method and study sample.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Asthma prevalence    in developing countries, characteristically low for a long time, seems to be    increasing following the urbanization and industrialization process &#91;<i>11</i>&#93;.    Possible explanations for this are: the sudden exposure to pollution from industrial    and motor vehicle exhaust emissions as a result of urbanization; a change in    diet resulting in a loss of protection against allergic diseases caused by <i>Lactobacillus</i>;    and a decrease in <i>Ascaris lumbricoides</i> infections which is considered    by some to have a role in protection against the development of asthma. The    effects of all these factors and of many others may be more important in younger    children &#91;<i>12</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Underdiagnosis    of asthma</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The number of children    who were aware that they had been diagnosed with asthma was considerably lower    than the number actually reporting wheezing. This might be partly explained    by the wheezing resulting from causes other than asthma, but the most likely    explanation is an underdiagnosis of the condition or a failure to apply the    diagnosis of asthma. This deficiency stems from a lack of recognition of atypical    or less common presentations of the condition, such as cough and symptom suggestive    of bronchial hyperactivity, and also from a reluctance to label a child as suffering    from asthma.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Underdiagnosed    asthma is common. In a recent study in North Carolina using the ISAAC protocol,    it was found that many children with underdiagnosed asthma miss school and require    emergency department visits, although those with a current diagnosis of asthma    report more use of resources &#91;<i>2,13</i>&#93;. In the ISAAC Steering Committee    study, the reporting of ever wheezing was much higher than the reporting of    asthma ever in some countries &#91;<i>5</i>&#93;. For example, the prevalence of ever    wheezing and asthma ever were respectively 6.2% and 2.5% in Ethiopia, 10.9%    and 2.7% in the Islamic Republic of Iran, 22.7% and 14.9% in Brazil, 28.1% and    16.5% in Canada, and 13.8% and 5.7% in Germany. In other countries, however,    there was much less wheezing ever than asthma ever (4.2% and 6.1% in China,    10.7% and 18.4% in Nigeria, 13.4% and 18.9% in Japan and 9.7% and 20.9% in Singapore    respectively).</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the Eastern    Mediterranean region, total wheezing ever and ever had asthma were 10.7%. In    the Islamic Republic of Iran, Lebanon, Malta, and Pakistan wheezing ever was    more prevalent than asthma ever. But in some countries the prevalence of asthma    ever was higher than ever wheezing. For example, the prevalence of ever wheezing    and asthma ever were respectively 17.0% and 17.5% in Kuwait, 16.0% and 11.1%    in Morocco, and 8.9%, and 20.7% in Oman &#91;<i>5</i>&#93;. Although the authors did    not give any explanation for this paradoxical finding, in our opinion there    are 2 possibilities: misunderstanding of questions by the students in their    study or resolution of childhood asthma as children grow older.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the <a href="#tab4">Table    4</a> the prevalence of wheezing in the previous 12 months and of ever asthma    in some centres that used the ISAAC protocol are shown for comparison. As can    be seen, underdiagnosis of asthma in Urmia is higher than other places, which    suggests a need to increase the awareness of both physicians and people regarding    wheezing and asthma.</font></p>     <p><a name="tab4"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a01tab04.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Sex differences</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In general, boys    had a higher prevalence of medical diagnosis and symptoms than girls with the    exception of eczema and eczema-related symptoms. This is similar to many other    studies but is different from the findings in most developed countries &#91;<i>14,15</i>&#93;.    Asthma is more frequent in young males than young females. However, after puberty,    asthma becomes more prevalent in females. By adulthood, the sex ratio (female:male)    of the incidence of asthma admission is 3 in the United States of America &#91;<i>14</i>&#93;.    In an ISAAC study in the north-east of England, there was a female predominance    in 13-14-year-old schoolchildren &#91;<i>14</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the ISAAC Steering    Committee study there was a mixed picture in 13-14-year-olds, with considerable    variation between countries &#91;<i>5</i>&#93;. On average, however, females had a slightly    higher prevalence than males. It is possible that the emergence of a female    predominance of asthma in older adolescents and adults may depend on physical    maturation, which is likely to occur at different ages in the range of countries    studied. This pattern of sex differences has been reported in other studies    in developed countries, including one large study which used ISAAC questionnaires    systematically across the age range 5-17 years. In Tehran, asthma was more prevalent    in girls &#91;<i>9</i>&#93;. Golshan et al. also reported a higher prevalence of asthma    in girls than boys in Zarinshahr &#91;<i>16</i>&#93; and they attributed it to the fact    that girls were indoors more and involved in baking, cooking and carpet weaving.    The difference with our results may be explained by the fact that Urmia is a    large city and cooking with biomass fuels and carpet weaving are not common    among girls.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Lower prevalence    in the video questionnaire</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The questionnaires    used in this study were specifically developed for international comparison    and both written and video questionnaires have been tested and validated against    bronchial hyper-responsiveness in both English-speaking and Chinese-speaking    communities &#91;<i>17</i>&#93;. In the present study, the prevalence of asthma obtained    using the video questionnaire was lower than that obtained with the written    questionnaire, independent of sex. This finding is similar to most other ISAAC    studies. Crane et al. reported a higher prevalence in the written questionnaire    in 90 centres but the opposite in 9 centres &#91;<i>18</i>&#93;. In contrast to our    finding, Behbahani et al. reported a higher prevalence in the video questionnaire    in our neighbouring country Kuwait &#91;<i>7</i>&#93;. In our study the prevalence remained    higher in the written questionnaire even when a combination of 3 video sequences    on wheezing was used.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Risk factors    for asthma</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There was no positive    association between maternal smoking and the prevalence of wheezing in our study;    the low frequency of maternal smoking among the participants was probably the    reason for this finding.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Rhinitis and eczema    ever were strongly associated with current and ever wheezing. Various studies    have reported that atopic dermatitis and rhinitis are commoner in asthmatics.    The risk for asthma attributable to atopy has been estimated at 30% &#91;<i>12</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Children who stated    that their home was situated on a road with heavy traffic were more likely to    report wheezing than their colleagues who lived in quiet areas. Similar finding    have been reported in other studies &#91;<i>19,20</i>&#93;. The lack of catalytic converters    and the presence of old and dilapidated cars with high exhaust emissions in    our country are likely to play a role in this finding. Experimental evidence    obtained in studies on human volunteers, animals and <i>in vitro</i> test systems    suggests that diesel exhaust particles can enhance immunological responses to    allergens and also elicit inflammatory reactions in the airways at relatively    low concentrations and short exposure durations &#91;<i>21</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">More frequent acetaminophen    (paracetamol) use was strongly correlated with wheezing. In an ecological analysis    Newson et al. showed that paracetamol sales were high in English-speaking countries    and were positively associated with asthma symptoms, eczema and allergic rhinoconjunctivitis    in 13-14-year-olds, and with wheeze, diagnosed asthma, rhinitis and bronchial    responsiveness in adults &#91;<i>22</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Nasal problems    in the absence of an infection were an even commoner problem than wheezing in    our students. Again in this age group the boys suffered more than the girls.    The ISAAC Steering Committee study showed a 30-fold variation in the rate of    allergic rhinoconjunctivitis symptoms between centres (range 1.4% to 39.7%)    &#91;<i>4</i>&#93;. Our results are similar to those of Mirsaid Ghazi et al. &#91;<i>23</i>&#93;    who reported the prevalence of allergic rhinitis in Tehran to be 23.28% in 10-14-year-old    students and commoner in boys than girls.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">An itchy rash that    came and went for at least 6 months, which is suggestive of eczema, was the    least frequently reported of the 3 allergic conditions investigated in this    study. Surprisingly the prevalence of eczema ever was commoner than eczema symptoms.    It is possible that in the Islamic Republic of Iran most skin lesions are labeled    as eczema; however, the most probable explanation is our inappropriate translation    of the word eczema. Since there is no equivalent Persian word for "eczema" we    added the Persian word <i>hassasiat</i> in parenthesis in the translation of    the question "Have you ever had eczema?" <i>Hassasiat</i> is a Persian version    of an Arabic word and is used in our country interchangeably with the word "allergy".    This mistranslation probably led to an overestimation of eczema ever. Similarly    in an ISAAC study in Bangkok among university students, the use of the term    "allergic rash" for eczema led to an overestimation of the prevalence of eczema    &#91;<i>24</i>&#93;. The ISAAC Steering Committee study showed a 60-fold variation in    the prevalence of atopic eczema symptoms between centres (range 0.3%-20.5%)    &#91;<i>4</i>&#93;.</font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Conclusion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Our study showed    that the prevalence of asthma and allergic rhinoconjunctivitis is relatively    high, but they are still less prevalent than more developed countries. Paternal    smoking, acetaminophen use, residence on a busy road, male sex, rhinitis ever,    eczema ever and keeping a cat at home were all positively associated with wheezing.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Acknowledgements</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">This study was    approved and funded by Urmia University of Medical Sciences.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors would    like to thank the schoolchildren, teachers and other staff who participated    in the survey. This study would have been impossible without the help of Dr    Ali Hamzezadeh and other members of Urmia University of Medical Sciences and    the Students’ Research Committee and we are indebted to them. </font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>1.  Asthma</i>.    Geneva, World Health Organization, 2000 (WHO Fact sheet No. 206) (<a href="http://www.who.int/mediacentre/factsheets/fs307/en/index.html" target="_blank">http://www.who.int/mediacentre/factsheets/fs307/en/index.html</a>,    accessed 1 March 2007)</font></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2.   Bousquet J    et al. The public health implications of asthma. <i>Bulletin of the World Health    Organization</i>, 2005, 83:548-54.</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=003307&pid=S1020-3397200700050000300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3.   Asher MI et    al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale    and methods. <i>European respiratory journal</i>, 1995, 8:483-91.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4.   Worldwide    variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis,    and atopic eczema: ISAAC. The International Study of Asthma and Allergies in    Childhood (ISAAC) Steering Committee. <i>Lancet</i>, 1998, 351:1225-32.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5.   Worldwide    variations in the prevalence of asthma symptoms: the International Study of    Asthma and Allergies in Childhood (ISAAC). <i>European respiratory journal</i>,    1998, 12:315-5.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.   Ece A et al.    Prevalence of asthma and other allergic disorders among schoolchildren in Diyarbakir,    Turkey. <i>Turkish journal of pediatrics</i>, 2001, 43:286-92.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7.   Behbehani    NA et al. Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old    children in Kuwait: an ISAAC study. International Study of Asthma and Allergies    in Childhood. <i>Annals of allergy, asthma &amp; immunology</i>, 2000, 85:58-63.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8.   Al-Thamiri    D, Al-Kubaisy W, Ali S.H. Asthma prevalence and severity among primary-school    children in Baghdad.<i> Eastern Mediterranean health journal,</i> 2005, 11:79-86</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9.   Masjedi M    et al. Prevalence and severity asthma symptoms in children of Tehran International    Study of Asthma and Allergies in Childhood (ISAAC). <i>Iranian journal of allergy,    asthma &amp; immunology</i>, 2004, 3:25-30.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.  Golshan M    et al. Prevalence of asthma and related symptoms in primary school children    of Isfahan, Iran, in 1998. <i>Asian Pacific journal of allergy and immunology</i>,    2001, 19:163-70.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.  Weinberg EG.    Urbanization and childhood asthma: an African perspective. <i>Journal of allergy    and clinical immunology</i>, 2000, 105:224-31.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.  Viegi G, Annesi    I, Matteelli G. Epidemiology of asthma. <i>European respiratory monograph</i>,    2003, 23:1-25 </font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.  Yeatts K et    al. Health consequences for children with undiagnosed asthma-like symptoms.    <i>Archives of pediatric and adolescent medicine</i>, 2003. 157:540-4.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.  Shamssain    MH, Shamsian N. Prevalence and severity of asthma, rhinitis, and atopic eczema    in 13- to 14-year-old school-children from the northeast of England. <i>Annals    of allergy, asthma &amp; immunology</i>, 2001, 86:428-32.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.  Pekkanen J    et al. Prevalence of asthma symptoms in video and written questionnaires among    children in four regions of Finland. <i>European respiratory journal</i>, 1997,    10:1787-94.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.  Golshan M    et al. Prevalence of asthma and related symptoms in school-aged children in    Zarinshahr, Iran. <i>Tanaffos</i>, 2002, 1:41-6.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.  Gibson PG    et al. Validation of the ISAAC video questionnaire (AVQ3.0) in adolescents from    a mixed ethnic background. <i>Clinical and experimental allergy</i>, 2000, 30:1181-7.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.  Crane J et    al. Agreement between written and video questions for comparing asthma symptoms    in ISAAC. <i>European respiratory journal</i>, 2003, 21:455-61.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">19.  Montefort    S et al. Asthma, rhinitis and eczema in Maltese 13-15-year-old schoolchildren    - prevalence, severity and associated factors &#91;ISAAC&#93;. International Study of    Asthma and Allergies in Childhood. <i>Clinical and experimental allergy</i>,    1998, 28:1089-99.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">20.  Duhme H et    al. Asthma and allergies among children in West and East Germany: a comparison    between Munster and Greifswald using the ISAAC phase I protocol. International    Study of Asthma and Allergies in Childhood. <i>European respiratory journal</i>,    1998, 11:840-7.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">21.  Brunekreef    B, Sunyer J. Asthma, rhinitis and air pollution: is traffic to blame? <i>European    respiratory journal</i>, 2003, 21:913-5.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">22.  Newson RB    et al. Paracetamol sales and atopic disease in children and adults: an ecological    analysis. <i>European respiratory journal</i>, 2000, 16:817-23.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">23.  Mirsaid Ghazi    B et al. Frequency of allergic rhinitis in school-aged children (7-18 years)    in Tehran. <i>Iranian journal of allergy, asthma &amp; immunology</i>, 2003,    2:181-4.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">24.  Vichyanond    P et al. Prevalence of asthma, allergic rhinitis and eczema among university    students in Bangkok. <i>Respiratory medicine</i>, 2002, 96:34-8.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">25.  Kaur B et    al. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14 year old    children across Great Britain (international study of asthma and allergies in    childhood, ISAAC UK). <i>British medical journal</i>, 1998, 316:118-24.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">26.  El Sharif    N et al. Asthma prevalence in children living in villages, cities and refugee    camps in Palestine. <i>European respiratory journal</i>, 2002, 19:1026-34.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>27.  Manning    PJ et al. Asthma, hay fever and eczema in Irish teenagers (ISAAC protocol).    </i>Irish medical journal<i>, 1997, 90:110-2.</i></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Received: 18/05/05;    accepted: 31/10/05 </font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Facts about    asthma</b> </font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">• According to    World Health Organization (WHO) estimates, <b>300</b> million people suffer    from asthma and <b>255 000</b> people died of asthma in <b>2005</b>.    <br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">• Asthma    is the most common chronic disease among children.     <br>   • Asthma is not just a public health problem for high income countries: it occurs    in all countries regardless of level of development. Over <b>80%</b> of asthma    deaths occur in low and lower-middle income countries.      <br>   • Asthma deaths will increase by almost <b>20%</b> in the next <b>10</b> years    if urgent action is not taken.    <br>   • Asthma is under-diagnosed and under-treated, creating a substantial burden    to individuals and families and possibly restricting individuals’ activities    for a lifetime. </font></p>     <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Source:    WHO Fact sheet No. 307, August 2006    <br>     (<a href="http://www.who.int/mediacentre/factsheets/fs307/en/index.html" target="_blank">http://www.who.int/mediacentre/factsheets/fs307/en/index.html</a>)</font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bousquet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The public health implications of asthma]]></article-title>
<source><![CDATA[Bulletin of the World Health Organization]]></source>
<year>2005</year>
<volume>83</volume>
<page-range>548-54</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
